| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.57B | +83.0% |
| R&D Expense | $101.9M | +59.6% |
| SG&A Expense | $236.2M | -10.5% |
| Operating Income | $132.5M | +312.3% |
| Pre-tax Income | -$37.3M | +67.5% |
| Income Tax | -$2.4M | +44.1% |
| Net Income | -$34.8M | +68.4% |
| EPS (Basic) | -$0.20 | +73.0% |
| EPS (Diluted) | -$0.20 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $240.0M | +42.3% |
| Accounts Receivable | $297.3M | +11.4% |
| Current Assets | $561.7M | +18.0% |
| Total Assets | $3.83B | -2.3% |
| Current Liabilities | $230.5M | -8.1% |
| Long-term Debt | $2.11B | -2.2% |
| Total Liabilities | $2.52B | -3.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $195.1M | +592.0% |
| Capital Expenditures | $6.6M | +285.6% |
| Investing Cash Flow | -$54.1M | +96.7% |
| Financing Cash Flow | -$70.8M | -104.5% |
| Free Cash Flow | $188.5M | +611.9% |
| +73.0% |
| Stockholders' Equity |
| $1.31B |
| +0.5% |